Gunjan Garg1, Deepak Kumar2, Mohammad Asim1, Syed Akhtar Husain3, Bhudev C Das4, Premashis Kar1. 1. Department of Medicine, Maulana Azad Medical College, University of Delhi, New Delhi, India. 2. Department of Biotechnology & Molecular Medicine, Pt. B.D. Sharma Post Graduate Institute of Medical Sciences, Rohtak, India. 3. Department of Biosciences, Jamia Millia Islamia, New Delhi, India. 4. Ambedkar Center for Biomedical Research, University of Delhi, New Delhi, India.
Abstract
INTRODUCTION: The hepatitis B virus (HBV), HCV, and HEV may occur as singly or concurrently in patients of different kind of liver disease. The rapid, reliable, and cost-effective screening of these pathogens is required for the large epidemiological studies. Therefore, a study has been planned to develop a multiplex Reverse Transcriptase-PCR assay which can be used for the screening of maximum number of pathogens at a time. METHODOLOGY: To develop multiplex Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) assay for simultaneous detection of HBV, HCV, and HEV; the serum samples of 54 patients who were positive either singly or in co-infection with for HBV, HCV, and HEV serologically were screened by uniplex PCR/RT-PCR followed by multiplex RT-PCR for HBV, HCV, and HEV using specific primers. These primers can detect most genotypes of these viruses. Multiplex RT-PCR was done in one tube for the identification of viral DNA/RNA using a mixture of three pairs of specific primers for hepatitis B, C, and E viruses. Representative positive samples of these viruses by uniplex/multiplex RT-PCR were also confirmed by sequencing followed by alignment with reference strains sequence. RESULTS: The specificity of multiplex PCR was 100% with high sensitivity 89%, 87%, and 74% for HBV, HCV, and HEV respectively. The sensitivity and specificity of RT-multiplex PCR demonstrated a good correlation with that of uniplex PCR. CONCLUSION: The study suggests that multiplex RT-PCR can serve as a simple and reliable assay for rapid, sensitive, and cost-effective method for simultaneous detection of super-infections with HEV particularly in Asian countries as a cause of decompensation of chronic liver disease.
INTRODUCTION: The hepatitis B virus (HBV), HCV, and HEV may occur as singly or concurrently in patients of different kind of liver disease. The rapid, reliable, and cost-effective screening of these pathogens is required for the large epidemiological studies. Therefore, a study has been planned to develop a multiplex Reverse Transcriptase-PCR assay which can be used for the screening of maximum number of pathogens at a time. METHODOLOGY: To develop multiplex Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) assay for simultaneous detection of HBV, HCV, and HEV; the serum samples of 54 patients who were positive either singly or in co-infection with for HBV, HCV, and HEV serologically were screened by uniplex PCR/RT-PCR followed by multiplex RT-PCR for HBV, HCV, and HEV using specific primers. These primers can detect most genotypes of these viruses. Multiplex RT-PCR was done in one tube for the identification of viral DNA/RNA using a mixture of three pairs of specific primers for hepatitis B, C, and E viruses. Representative positive samples of these viruses by uniplex/multiplex RT-PCR were also confirmed by sequencing followed by alignment with reference strains sequence. RESULTS: The specificity of multiplex PCR was 100% with high sensitivity 89%, 87%, and 74% for HBV, HCV, and HEV respectively. The sensitivity and specificity of RT-multiplex PCR demonstrated a good correlation with that of uniplex PCR. CONCLUSION: The study suggests that multiplex RT-PCR can serve as a simple and reliable assay for rapid, sensitive, and cost-effective method for simultaneous detection of super-infections with HEV particularly in Asian countries as a cause of decompensation of chronic liver disease.
Entities:
Keywords:
ELISA, enzyme linked immunosorbent assay; HAV, hepatitis A virus; HBV, hepatitis B virus; HCV, hepatitis C virus; HEV, hepatitis E virus; NATs, nucleic acid amplification technologies; NPV, negative predictive value; PCR, polymerase chain reaction; PPV, positive predictive value; RT-PCR, Reverse Transcriptase-Polymerase Chain Reaction; hepatitis B virus; hepatitis C virus; hepatitis E virus; liver diseases; multiplex PCR
Authors: J A Vet; A R Majithia; S A Marras; S Tyagi; S Dube; B J Poiesz; F R Kramer Journal: Proc Natl Acad Sci U S A Date: 1999-05-25 Impact factor: 11.205
Authors: Lisa Y Cho; Jae Jeong Yang; Kwang-Pil Ko; Boyoung Park; Aesun Shin; Min Kyung Lim; Jin-Kyoung Oh; Sohee Park; Yoon Jun Kim; Hai-Rim Shin; Keun-Young Yoo; Sue K Park Journal: Int J Cancer Date: 2011-01-01 Impact factor: 7.396
Authors: Carlos Cantonero; Pedro Javier Camello; Carmen Abate; Francesco Berardi; Gines Maria Salido; Juan Antonio Rosado; Pedro C Redondo Journal: Cancers (Basel) Date: 2020-01-21 Impact factor: 6.639